MCQs
6530 questions found
A.
Persistent dry cough
✓
C.
Hypotension and bradycardia
✓
D.
Blue-grey skin discoloration
✓
A.
Auscultate lung sounds
✓
B.
Check the patient's blood pressure
✓
C.
Assess apical pulse for one full minute
✓
D.
Evaluate pupil reaction
✓
A.
One dose in 5 minutes
✓
B.
Two doses in 10 minutes
✓
C.
Three doses in 15 minutes
✓
D.
Four doses in 20 minutes
✓
B.
Persistent dry cough
✓
C.
Dizziness upon standing
✓
D.
Headache and blurred vision
✓
B.
QT interval prolongation.
✓
A.
Stimulating thyroid hormone release.
✓
B.
Inhibiting thyroid hormone synthesis.
✓
C.
Increasing iodine uptake by the thyroid gland.
✓
D.
Destroying thyroid follicular cells.
✓
B.
Hypertensive crisis.
✓
D.
Respiratory depression.
✓
A.
Addiction potential.
✓
C.
Respiratory depression.
✓
A.
Inhibiting fungal cell wall synthesis.
✓
B.
Inhibiting fungal DNA synthesis.
✓
C.
Inhibiting ergosterol synthesis, a critical component of the fungal cell membrane.
✓
D.
Disrupting fungal ribosomes.
✓
A.
Decreased metabolism of warfarin, leading to increased INR.
✓
B.
Increased metabolism of oral contraceptives, leading to reduced efficacy.
✓
C.
Decreased absorption of iron supplements.
✓
D.
Increased renal excretion of digoxin.
✓
B.
Tendonitis and tendon rupture.
✓
B.
Inhaled long-acting ?2?-agonist.
✓
C.
Systemic corticosteroids (e.g., intravenous methylprednisolone).
✓
A.
Primarily lowering LDL cholesterol.
✓
B.
Primarily lowering triglycerides and modestly raising HDL cholesterol.
✓
C.
Primarily raising total cholesterol.
✓
D.
Primarily raising LDL cholesterol.
✓
A.
To minimize adverse effects.
✓
B.
To simplify the dosing regimen.
✓
C.
To overcome and prevent antibiotic resistance.
✓
D.
To increase patient compliance.
✓
A.
Increasing insulin secretion.
✓
B.
Decreasing hepatic glucose production.
✓
C.
Inhibiting sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion.
✓
D.
Enhancing insulin sensitivity.
✓
B.
Inhibition of COX-2.
✓
C.
Irreversible inhibition of COX-1 in platelets, leading to reduced thromboxane A2.
✓
D.
Activation of plasminogen.
✓
